進行性骨化性線維異形成症（FOP）の成人患者を対象に、ガレトスマブとプラセボを静脈内（IV）投与した場合の安全性、忍容性、有効性を評価する試験

基本情報

NCT ID

NCT05394116

ステータス

実施中（募集終了）

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

63

治験依頼者名

Regeneron Pharmaceuticals

概要

This study is researching an experimental drug called garetosmab. The study is focused on adult patients with fibrodysplasia ossificans progressiva (FOP). The aim of the study is to see how safe and effective the study drug is in patients with FOP. The study is looking at several other research questions, including: * What side effects may happen from receiving the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)

対象疾患

介入

依頼者（Sponsor）

実施施設 (3)